Items where authors include "Hammond, D."
Article
Beck, D.B., Heiblig, M., Savic, S. orcid.org/0000-0001-7910-0554 et al. (12 more authors) (2026) PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome. Journal of Clinical Medicine, 15 (4). 1426. ISSN 2077-0383
Hutchinson, P.J., Pinkney, T., Mohan, M. et al. (137 more authors) (2024) From opera buffa to opera seria: anniversaries of Royal College of Surgeons of England research initiatives. British Journal of Surgery, 111 (1). znad412. ISSN 0007-1323
Smith, J.A. orcid.org/0000-0001-6889-4408, Game, O.S. orcid.org/0000-0002-5573-3602, Bishop, J.E. et al. (13 more authors) (2020) Rapid scalable processing of tin oxide transport layers for perovskite solar cells. ACS Applied Energy Materials, 3 (6). pp. 5552-5562. ISSN 2574-0962
Robshaw, T.J., Tukra, S., Hammond, D. et al. (2 more authors) (2019) Highly efficient fluoride extraction from simulant leachate of spent potlining via La-loaded chelating resin. An equilibrium study. Journal of Hazardous Materials, 361. pp. 200-209. ISSN 0304-3894
Ishizaka, K., Lewis, S., Hammond, D. et al. (1 more author) (2018) Chemistry of black leaf films synthesised using rail steels and their influence on the low friction mechanism. RSC Advances, 8 (57). pp. 32506-32521. ISSN 2046-2069
Burghel, G.J., Lin, W-Y., Whitehouse, H. et al. (6 more authors) (2013) Identification of Candidate Driver Genes in Common Focal Chromosomal Aberrations of Microsatellite Stable Colorectal Cancer. PLOS ONE, 8 (12). UNSP e83859. ISSN 1932-6203
Salawu, A., Ul-Hassan, A., Hammond, D. et al. (3 more authors) (2012) High Quality Genomic Copy Number Data from Archival Formalin-Fixed Paraffin-Embedded Leiomyosarcoma: Optimisation of Universal Linkage System Labelling. PLOS One, 7 (11). e50415. ISSN 1932-6203
Conference abstract
Weeks, L.D., Hammond, D., Savic, S. orcid.org/0000-0001-7910-0554 et al. (12 more authors) (2025) Development of a Consensus Definition of VEXAS Flare for Use in Clinical Research. [Conference abstract]
Byram, K., Mann, H., Hammond, D. et al. (23 more authors) (2025) Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI). [Conference abstract]
Beck, D., Heiblig, M., Savic, S. orcid.org/0000-0001-7910-0554 et al. (12 more authors) (2025) PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome. [Conference abstract]
Beck, D.B., Heiblig, M., Savic, S. orcid.org/0000-0001-7910-0554 et al. (12 more authors) (2025) PAXIS: a randomized, double-blind, placebo-controlled, dose finding phase 2 study (part 1) followed by an open-label period (part 2)to assess the efficacy and safety of pacritinib in patients with VEXAS syndrome. [Conference abstract]
Up a level